Pharmaceutical Industry Information Portal

HomeNews

News

Halozyme to acquire Antares Pharma in a $960 million deal

Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Halozyme will acquire Antares...

Omicron-specific vaccine candidates containing inactivated or “killed” coronaviruses approved for clinical trials

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong,...

Nektar Therapeutics and Bristol Myers Squibb stop clinical trials for key cancer drug

Nektar Therapeutics and Bristol Myers Squibb announced that based on results from pre-planned analyses of two late-stage clinical studies of bempegaldesleukin (BEMPEG) in combination...

FDA grants Regenerative Medicine Advanced Therapy designation to Direct Biologics’ extracellular vesicle drug for Covid-19

Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S. Food and Drug Administration has...

BioNTech plans to advance new formulations for mRNA vaccines in new research collaboration

BioNTech SE and Matinas BioPharma, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid...

RedHill reports powerful inhibition of Omicron SARS-CoV-2 variant by the oral drug candidate

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for hospitalized patients with moderate to...
spot_img

Expert Articles

spot_img